Alex Lam, PhD, is a Scientist 2 at Xencor since November 2022, following a progression from Scientist 1 in the same organization. Previously, Alex served as a Graduate Student Researcher at the University of California, Los Angeles from September 2017 to September 2022, where significant contributions included securing over $75,000 in competitive grants aimed at developing a vaccine for Kaposi Sarcoma-associated herpesvirus, generating and purifying a virus-like vesicle vaccine candidate, and elucidating the immune response mechanisms in murine models. Alex's academic background includes a PhD in Molecular and Medical Pharmacology and a Bachelor of Science in Chemistry from UCLA, with additional research experience as an Undergraduate Researcher in the Lipshutz Lab, focusing on gene therapy vectors and mouse model management. Academic achievements encompass multiple presentations and authorships in peer-reviewed journals.
This person is not in the org chart
This person is not in any teams
This person is not in any offices